Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine May/22/2021 12 1
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Paritaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 5 0
Daclatasvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 5 1
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 6 1
Gummadiol Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020 1 0
18-Hydroxy-3-epi-alpha-yohimbine Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020 1 0
Vincapusine Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020 1 0